Sr. Associate Scientist, Downstream Development for Protein Development & Manufacturing
Company: Vaxcyte Inc.
Location: San Carlos
Posted on: March 20, 2023
|
|
Job Description:
Company Profile:Vaxcyte, Inc. (Nasdaq: PCVX) is a vaccine
innovation company engineering high-fidelity vaccines to protect
humankind from the consequences of bacterial diseases. The Company
is developing broad-spectrum conjugate and novel protein vaccines
to prevent or treat bacterial infectious diseases. Vaxcyte's lead
candidate, VAX-24, is a 24-valent, broad-spectrum pneumococcal
conjugate vaccine being developed for the prevention of invasive
pneumococcal disease (IPD). The Company is re-engineering the way
highly complex immunizations are made through modern synthetic
techniques, including advanced chemistry and our exclusively
licensed XpressCFTM cell-free protein synthesis platform. Unlike
conventional cell-based approaches, the Company's system for
producing difficult-to-make proteins and antigens is intended to
accelerate its ability to efficiently create and deliver
high-fidelity vaccines with enhanced immunological benefits.
Vaxcyte's pipeline also includes VAX-XP, a PCV with an expanded
breadth of coverage of greater than 30 strains; VAX-A1, a
prophylactic vaccine candidate designed to prevent Group A Strep
infections; and VAX-PG, a therapeutic vaccine candidate designed to
slow or stop the progression of periodontal disease. The Company is
driven to eradicate or treat invasive bacterial infections, which
have serious and costly health consequences when left unchecked.
For more information, visit .Vaxcyte, headquartered in San Carlos,
CA, went public in June 2020 and currently has a team of
approximately 100 employees and anticipates continued, significant
growth. On January 6, 2022, Vaxcyte announced that the U.S. Food
and Drug Administration (FDA) had cleared the Investigational New
Drug (IND) application for VAX-24, its lead vaccine candidate. The
Company initiated the VAX-24 Phase 1/2 clinical proof-of-concept
study in adults in the first quarter of 2022 and expects to
announce Phase 2 topline immunogenicity, safety, and tolerability
results by the end of the year. VAX-24 was designed to prevent IPD,
which can be most serious for infants, young children, older adults
and those with immune deficiencies or certain chronic health
conditions. Given the global impact of pneumococcal disease remains
significant, the public health community continues to advocate for
vaccines that can offer broader protection to prevent IPD.
Vaxcyte's PCV franchise, consisting of VAX-24 and VAX-XP, is
designed specifically to address this need and has the potential to
deliver the broadest protection for this very serious
disease.Summary:Vaxcyte is looking for an energetic and talented
individual to join our protein process development and
manufacturing group. As a member of this group, you'll have the
opportunity to work with cutting edge technologies to design
purification processes for life-saving vaccines. The successful
candidate will have the following skills and qualities: -An
exceptional team member that fosters a highly collaborative work
environment. -A confident individual who speaks up, is open to
input, and remains focused on achieving the best results to achieve
company goals. -A diligent scientist/engineer who enjoys process
execution and scale up. -The ability to clearly present data, trend
longitudinal data, draw conclusions, and communicate salient points
concisely. -A strong sense of ownership and accountability;
commitment to Vaxcyte's mission.Essential Functions:
Keywords: Vaxcyte Inc., San Francisco , Sr. Associate Scientist, Downstream Development for Protein Development & Manufacturing, Other , San Carlos, California
Click
here to apply!
|